At the beginning of the COVID-19 pandemic, Rady Johnson and Beth Holly knew their companies needed to be transparent when creating and rolling out treatments for the never-before-seen virus.
From the outset of the pandemic, Johnson, the chief compliance, quality and risk officer at Pfizer in New York, and Holly, the chief compliance officer at Regeneron Pharmaceuticals Inc. in Tarrytown, New York, acknowledged public skepticism of the pharmaceutical industry.
Regeneron Stock – Public Trust Is Key Ingredient to Fight COVID-19, Say Pfizer, Regeneron Compliance Chiefs
Tags: Regeneron Stock, NASDAQ: REGN, Regeneron Pharmaceuticals
Stock Market, Latest News on C N N.